Pre-made Navivumab benchmark antibody ( Whole mAb, anti-Influenza A HA therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-368

Pre-Made Navivumab biosimilar, Whole Mab: Anti-Influenza A HA therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package List Price(In USD) Discount off Discount Price
GMP-Bios-ab-368-1mg 1mg 3090 30% 2163

Size: 1mg | 10mg | 100mg



Description

Products Name (INN Index) Pre-Made Navivumab biosimilar, Whole Mab: Anti-Influenza A HA therapeutic antibody
INN Name Navivumab
TargetInfluenza A HA
FormatWhole mAb
DerivationHuman
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Preclinical
Est. StatusDiscontinued
100% SI Structure4r8w:HL
99% SI Structure6fg1:HL/6fg2:HL
95-98% SI StructureNone
Year Proposed2015
Year Recommended2016
CompaniesCelltrion
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedInfluenza A virus H1N1 subtype;Influenza A virus H5N1 subtype;Influenza virus infections
Development Techna